Page 111 - 《中国药房》2025年6期

[10] BERGER M，AMINI-ADLÉ M，CRUMBACH L，et al. A （1）：142-146.
case of immune thrombocytopaenia induced by pembroli‐ [23] THIBULT M L，MAMESSIER E，GERTNER-DARDENNE
zumab in a metastatic melanoma patient with a history of J，et al. PD-1 is a novel regulator of human B-cell activa‐
immune-mediated pure red cell aplasia[J]. Eur J Cancer， tion[J]. Int Immunol，2013，25（2）：129-137.
2019，112：94-97. [24] OSORIO J C，NI A，CHAFT J E，et al. Antibody-mediated
[11] NI D，ALZAHRANI F，SMYLIE M. AIHA and pancyto‐ thyroid dysfunction during T-cell checkpoint blockade in
penia as complications of pembrolizumab therapy for patients with non-small-cell lung cancer[J]. Ann Oncol，
metastatic melanoma：a case report[J]. Case Rep Oncol， 2017，28（3）：583-589.
2019，12（2）：456-465. [25] SEKI M，URUHA A，OHNUKI Y，et al. Inflammatory
[12] GODA S，TSUJI T，MATSUMOTO Y，et al. A case of myopathy associated with PD-1 inhibitors[J]. J Autoim‐
non-small cell lung cancer with danazol-dependent aplas‐ mun，2019，100：105-113.
tic anemia induced by pembrolizumab[J]. Curr Probl Can‐ [26] 中华医学会血液学分会红细胞疾病（贫血）学组. 再生障
cer，2021，45（3）：100686. 碍性贫血诊断与治疗中国指南：2022年版[J]. 中华血液
[13] ISODA A， MIYAZAWA Y， TAHARA K， et al. 学杂志，2022，43（11）：881-888.
Pembrolizumab-induced pure red cell aplasia successfully Red Blood Cell Disease（Anemia） Group，Chinese So-
treated with intravenous immunoglobulin[J]. Intern Med， ciety of Hematology，Chinese Medical Association.Guide‐
2020，59（16）：2041-2045. lines for the diagnosis and management of aplastic anemia
[14] MERI-ABAD M，CUNQUERO TOMÁS A J，JAIME A in China：2022[J]. Chin J Hematol，2022，43（11）：
B. Unexpected pure red series aplastic anemia secondary 881-888.
to pembrolizumab treatment：a case report and literature [27] DELANOY N，MICHOT J M，COMONT T，et al. Haema‐
review[J]. Melanoma Res，2021，31（2）：186-189. tological immune-related adverse events induced by anti-
[15] YEUNG C，RELKE N，GOOD D，et al. Antithymocyte PD-1 or anti-PD-L1 immunotherapy：a descriptive obser‐
globulin for aplastic anemia secondary to pembrolizumab： vational study[J]. Lancet Haematol，2019，6（1）：e48-e57.
a case report and review of literature[J]. Immunotherapy， [28] GUO Q，ZHAO J N，LIU T，et al. Immune checkpoint
2023，15（5）：323-333. inhibitor-induced aplastic anaemia：case series and large-
[16] KUMAR V，MONTGOMERY N D，VAN DEVENTER H scale pharmacovigilance analysis[J]. Front Pharmacol，
W，et al. Waldenström macroglobulinemia with secondary 2023，14：1057134.
pure red cell aplasia in a patient with metastatic castrate [29] GUO Q，GAO J，GUO H，et al. Immune checkpoint
resistant prostate cancer receiving an immune checkpoint inhibitor-induced pure red cell aplasia：case series and
inhibitor：a case report[J]. J Med Case Rep，2023，17 large-scale pharmacovigilance analysis[J]. Int Immuno‐
（1）：220. pharmacol，2023，114：109490.
[17] HIRAI T，INOMATA M，MINATOYAMA S，et al. Pure [30] DAVIS E J，SALEM J E，YOUNG A，et al. Hematologic
red cell aplasia and chromosomal abnormality in a patient complications of immune checkpoint inhibitors[J]. On‐
with lung adenocarcinoma receiving immune checkpoint cologist，2019，24（5）：584-588.
inhibitors：a case report[J]. In Vivo，2024，38（3）：1509- [31] 中华医学会血液学分会红细胞疾病（贫血）学组. 获得性
1511. 纯红细胞再生障碍诊断与治疗中国专家共识：2020年版
[18] YOUNG N S. Aplastic anemia[J]. N Engl J Med，2018， [J]. 中华血液学杂志，2020，41（3）：177-184.
379（17）：1643-1656. Red Blood Cell Disease（Anemia） Group，Chinese So-
[19] YOUNAN R G，RAAD R A，SAWAN B Y，et al. Aplastic ciety of Hematology，Chinese Medical Association. Chinese
anemia secondary to dual cancer immunotherapies a physi‐ expert consensus on the diagnosis and treatment of ac‐
cian nightmare：case report and literature review[J]. Al‐ quired pure red cell aplasia：2020[J]. Chin J Hematol，
lergy Asthma Clin Immunol，2021，17（1）：112. 2020，41（3）：177-184.
[20] WANG L，LIU H. Pathogenesis of aplastic anemia[J]. He‐ [32] BRAHMER J R，ABU-SBEIH H，ASCIERTO P A，et al.
matology，2019，24（1）：559-566. Society for Immunotherapy of Cancer（SITC） clinical
[21] MEANS R T J R. Pure red cell aplasia[J]. Blood，2016， practice guideline on immune checkpoint inhibitor-related
128（21）：2504-2509. adverse events[J]. J Immunother Cancer，2021，9（6）：
[22] LIU M，LIU T，MENG W T，et al. Role of gammadelta T e002435.
cells in pathogenesis of acquired pure red cell aplastic ane‐ （收稿日期：2024-08-26 修回日期：2025-02-20）
mia[J]. Zhongguo Shi Yan Xue Ye Xue Za Zhi，2007，15 （编辑：李 劲）

中国药房 2025年第36卷第6期 China Pharmacy 2025 Vol. 36 No. 6 · 741 ·